rs1194182

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000309881.11(CD36):​c.-375G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.528 in 151,940 control chromosomes in the GnomAD database, including 22,221 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 22221 hom., cov: 32)
Exomes 𝑓: 0.39 ( 0 hom. )

Consequence

CD36
ENST00000309881.11 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0130

Publications

20 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 7-80602188-G-C is Benign according to our data. Variant chr7-80602188-G-C is described in ClinVar as Benign. ClinVar VariationId is 360740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD36NM_001001547.3 linkc.-375G>C upstream_gene_variant NP_001001547.1
CD36NM_001371074.1 linkc.-371G>C upstream_gene_variant NP_001358003.1
CD36NM_001371075.1 linkc.-375G>C upstream_gene_variant NP_001358004.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD36ENST00000309881.11 linkc.-375G>C 5_prime_UTR_variant Exon 1 of 14 1 ENSP00000308165.7
CD36ENST00000480599.6 linkn.39G>C non_coding_transcript_exon_variant Exon 1 of 3 2
CD36ENST00000435819.5 linkc.-183-43900G>C intron_variant Intron 4 of 16 2 ENSP00000399421.1

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80118
AN:
151804
Hom.:
22183
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.680
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.438
Gnomad ASJ
AF:
0.449
Gnomad EAS
AF:
0.682
Gnomad SAS
AF:
0.711
Gnomad FIN
AF:
0.463
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.446
Gnomad OTH
AF:
0.495
GnomAD4 exome
AF:
0.389
AC:
7
AN:
18
Hom.:
0
Cov.:
0
AF XY:
0.333
AC XY:
4
AN XY:
12
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.375
AC:
6
AN:
16
Other (OTH)
AF:
0.500
AC:
1
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.411
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.528
AC:
80205
AN:
151922
Hom.:
22221
Cov.:
32
AF XY:
0.531
AC XY:
39426
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.680
AC:
28209
AN:
41464
American (AMR)
AF:
0.438
AC:
6680
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.449
AC:
1557
AN:
3468
East Asian (EAS)
AF:
0.681
AC:
3495
AN:
5130
South Asian (SAS)
AF:
0.711
AC:
3425
AN:
4820
European-Finnish (FIN)
AF:
0.463
AC:
4884
AN:
10554
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.446
AC:
30308
AN:
67924
Other (OTH)
AF:
0.500
AC:
1053
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1878
3756
5634
7512
9390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
696
1392
2088
2784
3480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.467
Hom.:
9643
Bravo
AF:
0.525
Asia WGS
AF:
0.711
AC:
2470
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Platelet-type bleeding disorder 10 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
4.1
DANN
Benign
0.64
PhyloP100
-0.013
PromoterAI
-0.0074
Neutral
Mutation Taster
=292/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1194182; hg19: chr7-80231504; API